PBI-4050 is a novel compound developed by ProMetic Life Sciences Inc. possessing anti-inflammatory and anti-fibrotic effects. PBI-4050 targets a family of cell receptor(s) expressed throughout the body, which are involved in diseases marred by fibrosis and inflammation. The first aim is designed to test PBI-4050’s efficacy preserving kidney function in a mouse model of advanced […]
Read More